These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
98 related items for PubMed ID: 7951541
1. Plasma polymorphonuclear elastase in patients with hyperthyroidism. Hara H, Ban Y. Endocr J; 1993 Dec; 40(6):711-4. PubMed ID: 7951541 [Abstract] [Full Text] [Related]
2. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease. Takasu N, Kamijo K, Sato Y, Yoshimura H, Nagata A, Ochi Y. Clin Exp Pharmacol Physiol; 2004 Dec; 31(5-6):314-9. PubMed ID: 15191404 [Abstract] [Full Text] [Related]
3. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Noh JY, Hamada N, Inoue Y, Abe Y, Ito K, Ito K. Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459 [Abstract] [Full Text] [Related]
6. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. Carella C, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Pilla P, Nersita R, Iorio S, Amato G, Braverman LE, Roti E. Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093 [Abstract] [Full Text] [Related]
7. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. Ohara N, Kaneko M, Kitazawa M, Uemura Y, Minagawa S, Miyakoshi M, Kaneko K, Kamoi K. J Med Case Rep; 2017 Feb 06; 11(1):32. PubMed ID: 28162094 [Abstract] [Full Text] [Related]
8. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T. Thyroid; 1999 Oct 06; 9(10):979-88. PubMed ID: 10560951 [Abstract] [Full Text] [Related]
9. Urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with Graves' disease, subacute thyroiditis, and silent thyroiditis: a longitudinal study. Nakamura S, Ishiyama M, Kosaka J, Mutoh J, Umemura N, Harase C. Endocrinol Jpn; 1991 Jun 06; 38(3):303-8. PubMed ID: 1794337 [Abstract] [Full Text] [Related]
17. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease. Kawakami-Tani T, Fukawa E, Tanaka H, Abe Y, Makino I. Metabolism; 1997 Oct 06; 46(10):1184-8. PubMed ID: 9322804 [Abstract] [Full Text] [Related]
18. [Incidental differentiated thyroid carcinoma is less prevalent in Graves' disease than in multinodular goiter]. Pascual Corrales E, Príncipe RM, Laguna Muro S, Martínez Regueira F, Alcalde Navarrete JM, Guillén Grima F, Galofré JC. Endocrinol Nutr; 2012 Mar 06; 59(3):169-73. PubMed ID: 22325789 [Abstract] [Full Text] [Related]